Patent details

Basic Information

Publication number:

EP3056216

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151546298

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Cancer therapy with a parvovirus combined with bevacizumab

French Title of Invention:

Thérapie anticancéreuse avec un parvovirus combiné avec du bévacizumab

German Title of Invention:

Krebstherapie mit einem Parvovirus in Kombination mit Bevacizumab

SPC Number:

Dates

Filing date:

11/02/2015

Grant date:

01/02/2017

EP Publication Date:

01/02/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/08/2016

EP B1 Publication Date:

01/02/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/02/2017

Expiration date:

11/02/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/02/2015

 

 

Name:

Deutsches Krebsforschungszentrum

Address:

Im Neuenheimer Feld 280, 69120 Heidelberg, Germany (DE)

Name:

Ruprecht-Karls-Universität

Address:

Grabengasse 1, 69117 Heidelberg, Germany (DE)

Inventor

1

Name:

GELETNEKY Karsten

Address:

Germany (DE)

2

Name:

ROMMELAERE Jean

Address:

Germany (DE)

3

Name:

WICK Antje

Address:

Germany (DE)

4

Name:

WICK Wolfgang

Address:

Germany (DE)

5

Name:

DAHM Michael

Address:

Germany (DE)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages